Acceptance of COVID-19 Vaccination and its Related Determinants among Adult Population in India
Background: SARS-Cov-2 (severe acute respiratory syndrome coronavirus 2) infection emerged as an epidemic and it was declared as a pandemic by the world health organization (WHO). Vaccines are developed to induce viral immunity, and vaccinating the entire population is urgent to limit the spread of the pandemic. Attaining herd immunity can be difficult with less vaccine acceptance.
Methodology: A cross-sectional study was conducted by using the snowball sampling technique. The survey was done between April 29, 2020 and May 19, 2020. The total number of responses obtained was 526. The questionnaire used in this study was based on previously conducted studies to estimate the rate of COVID-19 vaccine acceptance.
Result: 97.7% of the people that participated in the study were aware about the vaccine and said that they would be able to explain what a vaccine was. 82.9% of the respondents think that they are risking their own health and the health of their family by not getting vaccinated.
This study reports that the majority of population shows acceptance of the COVID-19, however it is evident from the other study results that this rate of acceptance is not sufficient. It is essential to identify the causes for hesitancy and ways to enhance the acceptance rates. By identification of these factors, healthcare professionals can develop techniques to strategies to work on areas that cause hesitancy among people and address their concerns. The demographical variations play a major role in determining the acceptance
Conclusion: In this COVID-19 pandemic, the most promising weapon for preventing the infection is the vaccine. More awareness and education about the need for vaccination and the hazards of avoiding the vaccine should be provided to people from authenticated sources.
Keywords: COVID-19, COVID-19 vaccine, cross- sectional study, vaccine acceptance, vaccine hesitancy.
2. WHO Coronavirus (COVID-19) Dashboard . World health organization;2020.Available at :https://covid19.who.int. Accessed June 20 2021.
3. Novel Coronavirus (2019-nCoV) SITUATION REPORT - 1 . World health organization;2020. Available at:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf.Accessed June 20 2021.
4. Sharma A, Tiwari S, Deb MK, Marty JL, Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies, Int J Antimicrob Agents, 2020; 56(2):106054-106056 https://doi.org/10.1016/j.ijantimicag.2020.106054
5. Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization;2020. Available at :https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.Accessed June 20,2021.
6. Sarkar K, Khajanchi S, Nieto JJ, Modeling and forecasting the COVID-19 pandemic in India,Chaos Solitons Fractals, 2020;139(1):110049-110051 https://doi.org/10.1016/j.chaos.2020.110049
7. Unlock 5.0 guidelines live: International flights to remain suspended till October 31.The Times of India;2020.Available at: https://timesofindia.indiatimes.com/india/coronavirus-in-india-live-updates-sept-29/liveblog/78375189.cms, Accessed June 20, 2021.
8. Overall Covid-19 situation stabilizing in India: Govt . The Times of India; 2021.Available at: https://timesofindia.indiatimes.com/india/overall-covid-19-situation-stabilising-in-india-govt/articleshow/82661261.cms.Accessed June 20, 2021.
9. Pandey SC, Pande V, Sati D, Upreti S, Samant M, Vaccination strategies to combat novel Corona Virus SARS-Cov-2, Life Sci,2020; 256 (1):117956-117958 . https://doi.org/10.1016/j.lfs.2020.117956
10. Corona virus vaccine tracker. The New York Times;2020.Available at: https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html. Accessed June 20, 2021.
11. Almond J, Hacker J, Harwood C, Pizza M, Rappuoli R, Ron EZ, Development of vaccines at the time of COVID-19, microLife, 2020; 1(1):1-12. https://doi.org/10.1093/femsml/uqaa003
12. WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out, World Health Organization;2021.Available at : https://www.who.int/news/item/15-02-2021-who-lists-two-additional-covid-19-vaccines-for-emergency-use-and-covax-roll-out#:~:text=Today%20WHO%20listed%20two%20versions,the%20Serum%20Institute%20of%20India. Accessed June 20, 2021.
13. Worldwide Covid-19 Candidate Vaccines, Indian Medical Council Research. India; 2020. Available at : https://vaccine.icmr.org.in/covid-19-vaccine. Accessed June 20, 2021.
14. Jabaris SL, V A, The current situation of COVID-19 in India, Brain Behav Immun Health, 2021; 11(1):100200-100203 https://doi.org/10.1016/j.bbih.2021.100200
15. Press Statement by the Drugs Controller General of India (DCGI) on Restricted Emergency approval of COVID-19 virus vaccine, Press Information Bureau Government of India;2021.Available at: https://www.icmr.gov.in/pdf/press_realease_files/HFW_DCGI_energency_use_authorisation_03012021_2.pdf. Accessed June 20,2021.
16. India's Historic Vaccination Drive: Evaluating the Stakes, Hurdles and Opportunities, Observer Research Foundation, 2021.Available at: https://www.orfonline.org/research/india-historic-vaccination-drive-evaluating-stakes-hurdles-opportunities/.Accessed June 20 ,2021.
17. COVAX-World for global equitable access to COVID-19 vaccines , World health organization;2020.Available at:https://www.who.int/initiatives/act-accelerator/covax.Accessed June 20,2021.
18. Lazarus JV, Ratzan SC, Palayewe A, A global survey of potential acceptance of a COVID-19 vaccine, Nat Med,2021; 27(1):225-228. https://doi.org/10.1038/s41591-020-1124-9
19. M. Al-Mohaithef, B. Padhi, Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey,Journal of Multidisciplinary Healthcare,2020;13(1):1657-1663 https://doi.org/10.2147/JMDH.S276771
20. Schaffer DeRoo S, Pudalov NJ, Fu LY, Planning for a COVID-19 Vaccination Program, JAMA, 2020; 323(24):2458-2459. https://doi.org/10.1001/jama.2020.8711
21. Malik AA, McFadden SM, Elharake J, Omer SB, Determinants of COVID-19 vaccine acceptance in the US, EClinicalMedicine, 2020; 26 (1):100495-100503. https://doi.org/10.1016/j.eclinm.2020.100495
22. Malesza M, Bozym M, Factors influencing COVID-19 vaccination uptake in an elderly sample in Poland, medRxiv, 2021; 1(1):1-18. https://doi.org/10.1101/2021.03.21.21254047
23. Alqudeimat Y, Alenezi D, AlHajri B, Alfouzan H, Almokhaizeem Z, Altamimi S, Acceptance of a COVID-19 Vaccine and Its Related Determinants among the General Adult Population in Kuwait, Med Princ Pract, 2021; 30(3):262-271. https://doi.org/10.1159/000514636
24. Goldman RD, Yan TD, Seiler M, Cotanda CP, Brown JC, Klein EJ, et al, International COVID-19 Parental Attitude Study (COVIPAS) Group. Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey, Vaccine, 2020; 38(48):7668-7673. https://doi.org/10.1016/j.vaccine.2020.09.084
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).